Search Results - "Morse, Ryan T."

Radiosensitivity of Breast Cancer Cells Is Dependent on the Organ Microenvironment by Guo, Genyan, Morse, Ryan T, Wang, Jie, Chen, Xuan, Zhang, Jiajie, Wang, Andrew Z

“…Distant metastasis is the leading risk factor of death in breast cancer patients, with lung and liver being commonly involved sites of distant seeding. Ongoing…”
Get full text

Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast Cancer by Morse, Ryan T., Moreno, Matthew, Butterworth, James A., Mitchell, Melissa P.

“…Oncoplastic breast surgery (OBS) combines breast cancer tumor removal with the cosmetic benefits of plastic surgery at the time of breast-conserving surgery…”
Get full text

Hypoxic Cell Radiosensitization in Head and Neck Squamous Cell Carcinoma: Running Out of Air by Morse, Ryan T., Mell, Loren K.

Get full text

Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma by Morse, Ryan T., Beaty, Brian, Scanga, Lori, Blumberg, Jeff, Patel, Samip, Yarbrough, Wendell G., Lumley, Catherine, Hackman, Trevor, Shen, Colette, Gupta, Gaorav P., Chera, Bhisham S.

“…•Initial FNA was diagnostic for malignancy in 73.6% patients.•Final yield of FNA biopsies to diagnose malignancy and p16 status was 47.3%.•Non-diagnostic FNA…”
Get full text

Neoadjuvant Radiotherapy Facility Type Affects Anastomotic Complications After Esophagectomy by Morse, Ryan T., Mouw, Tyler J., Moreno, Matthew, Erwin, Jace T., Cao, Ying, DiPasco, Peter, Al-Kasspooles, Mazin, Hoover, Andrew

“…Background Esophagectomy is a complex oncologic surgery that results in lower perioperative morbidity and mortality when performed in high-volume hospitals by…”
Get full text

Corrigendum to “Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma” [Oral Oncol. 134 (2022) 106131] by Morse, Ryan T., Beaty, Brian, Scanga, Lori, Blumberg, Jeff, Patel, Samip, Yarbrough, Wendell G., Lumley, Catherine, Hackman, Trevor, Shen, Colette, Gupta, Gaorav P., Chera, Bhisham S.

Get full text

Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative Risk by Morse, Ryan T., Nelson, Tyler J., Liu, Hannah C., Sangchan, Prangrawee, Chitti, Bhargava, Thompson, Caroline A., Henderson, Gerald, Williamson, Casey W., Todd, Jake R., Prajapati, Divya P., Vitzthum, Lucas K., Sharabi, Andrew B., Zou, Jingjing, Sacco, Assuntina G., Coffey, Charley S., Sanghvi, Parag, Rahn, Douglas A., Lominska, Christopher E., Shen, Colette J., Chera, Bhishamjit S., Mell, Loren K.

“…Randomized trials have found that patients with locoregionally advanced p16+ oropharyngeal squamous cell carcinoma (OPSCC) do not benefit from treatment…”
Get full text

Stereotactic Body Radiation Therapy for Apical Lung Tumors: Dosimetric Analysis of the Brachial Plexus and Preliminary Clinical Outcomes by Morse, Ryan T., Doke, Kaleigh, Ganju, Rohit G., Sood, Sumit, Mavroidis, Panayiotis, Chen, Allen M.

“…Dosimetric constraints of the brachial plexus have not yet been well-established for patients undergoing stereotactic body radiation therapy (SBRT). This study…”
Get full text

Sarcopenia and Treatment Toxicity in Older Adults Undergoing Chemoradiation for Head and Neck Cancer: Identifying Factors to Predict Frailty by Morse, Ryan T, Ganju, Rohit G, Gan, Gregory N, Cao, Ying, Neupane, Prakash, Kakarala, Kiran, Shnayder, Yelizaveta, Lominska, Christopher E

“…This study was performed to identify treatment related toxicities in older adults undergoing concurrent chemoradiotherapy for head and neck cancer and…”
Get full text

Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy by Morse, Ryan T., Bean, Nathan W., Hall, Jacob, Deal, Allison, Nyrop, Kirsten A., Abdou, Yara, Dees, Elizabeth C., Ray, Emily M., Jolly, Trevor A., Reeder-Hayes, Katherine E., Jones, Ellen, Gupta, Gaorav P., Elmore, Shekinah, Muss, Hyman B., Casey, Dana L.

“…Understanding quality of life (QOL) implications of individual components of breast cancer treatment is important as systemic therapies continue to improve…”
Get full text

Treatment Tolerance of Cetuximab versus Alternative Chemotherapy Agents in Non-Cisplatin Candidates with Head and Neck Cancer Receiving Concurrent Chemoradiotherapy by Morse, Ryan T, Ganju, Rohit G, Neeranjun, Rishi, Gan, Gregory N, Cao, Ying, Neupane, Prakash, Kakarala, Kiran, Shnayder, Yelizaveta, Lominska, Christopher E

“…Standard of care for radiosensitization in head and neck squamous cell carcinoma (HNSCC) is concurrent chemoradiotherapy (CCRT) with high-dose cisplatin. The…”
Get more information

Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinoma by Morse, Ryan T., Ganju, Rohit G., TenNapel, Mindi J., Neupane, Prakash, Kakarala, Kiran, Shnayder, Yelizaveta, Chen, Allen M., Lominska, Christopher E.

“…Background Triweekly high‐dose cisplatin (100 mg/m2) with concurrent radiation therapy is the current standard of care in the definitive or appropriate…”
Get full text